Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Potential biochemical markers to identify severe cases among COVID-19 patients

Jialin Xiang, Jing Wen, Xiaoqing Yuan, Shun Xiong, Xue Zhou, Changjin Liu, Xun Min
doi: https://doi.org/10.1101/2020.03.19.20034447
Jialin Xiang
1Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Wen
2Department of Medical Imaging, Affiliated Hospital of Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoqing Yuan
3Department of Laboratory Medicine, The Fourth People’s Hospital of Zunyi city, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shun Xiong
4School of Laboratory Medicine, Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xue Zhou
4School of Laboratory Medicine, Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changjin Liu
1Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 410642933@qq.com liuxin_zyfy@163.com
Xun Min
1Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 410642933@qq.com liuxin_zyfy@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

There is a high mortality and long hospitalization period for severe cases with 2019 novel coronavirus disease (COVID-19) pneumonia. Therefore, it makes sense to search for a potential biomarker that could rapidly and effectively identify severe cases early. Clinical samples from 28 cases of COVID-19 (8 severe cases, 20 mild cases) in Zunyi District from January 29, 2020 to February 21, 2020 were collected and otherwise statistically analysed for biochemical markers. Serum urea, creatinine (CREA) and cystatin C (CysC) concentrations in severe COVID-19 patients were significantly higher than those in mild COVID-19 patients (P<0.001), and there were also significant differences in serum direct bilirubin (DBIL), cholinesterase (CHE) and lactate dehydrogenase (LDH) concentrations between severe and mild COVID-19 patients (P<0.05). Serum urea, CREA, CysC, DBIL, CHE and LDH could be used to distinguish severe COVID-19 cases from mild COVID-19 cases. In particular, serum biomarkers, including urea, CREA, CysC, which reflect glomerular filtration function, may have some significance as potential indicators for the early diagnosis of severe COVID-19 and to distinguish it from mild COVID-19. Glomerular filtration function injury in severe COVID-19 patients should also be considered by clinicians.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Ethics Committee of the Affiliated Hospital of Zunyi Medical University No. KLL-2020-008

Funding Statement

This study was supported by the Science and Technology Program of Zunyi (Zunshikeheshezi [2018]103), the Undergraduate Innovation and Entrepreneurship Training Program of Zunyi Medical University (ZYDC2019093).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data, models, and code generated or used during the study appear in the submitted article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Potential biochemical markers to identify severe cases among COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Potential biochemical markers to identify severe cases among COVID-19 patients
Jialin Xiang, Jing Wen, Xiaoqing Yuan, Shun Xiong, Xue Zhou, Changjin Liu, Xun Min
medRxiv 2020.03.19.20034447; doi: https://doi.org/10.1101/2020.03.19.20034447
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Potential biochemical markers to identify severe cases among COVID-19 patients
Jialin Xiang, Jing Wen, Xiaoqing Yuan, Shun Xiong, Xue Zhou, Changjin Liu, Xun Min
medRxiv 2020.03.19.20034447; doi: https://doi.org/10.1101/2020.03.19.20034447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)